GTR 110624182
Bids Are Invited For The Purpose Of This Contract Is The Acquisition Of Medicines Intended To Comply With Judicial Decisions Of A Continuous And Unpredictable Nature Issued Against The State Of Rio Grande Do Norte, Which Determine The Regular And Uninterrupted Supply Of Medicines To Beneficiary Patients, Observing The Technical, Quantitative Specifications And Other Conditions Contained In This Terms Of Reference And In The Preliminary Technical Study Id 39444098.
ICB — International Competitive Bid
Closed
South America
Tender Information
GTR Reference
110624182
Tendering Authority
Subscribe to view
Tender No
90032/2026
Financer Name
Self-Funded
Work Title
Bids Are Invited For The Purpose Of This Contract Is The Acquisition Of Medicines Intended To Comply With Judicial Decisions Of A Continuous And Unpredictable Nature Issued Against The State Of Rio Grande Do Norte, Which Determine The Regular And Uninterrupted Supply Of Medicines To Beneficiary Patients, Observing The Technical, Quantitative Specifications And Other Conditions Contained In This Terms Of Reference And In The Preliminary Technical Study Id 39444098.
Bid Type
ICB — International Competitive Bid
Country
Subscribe to view
Geographical Region
South America
Political Region
BRIC,G20
Last Date of Bid Submission
31-03-2026
Closed
Work Detail
The Purpose Of This Contract Is The Acquisition Of Medicines Intended To Comply With Judicial Decisions Of A Continuous And Unpredictable Nature Issued Against The State Of Rio Grande Do Norte, Which Determine The Regular And Uninterrupted Supply Of Medicines To Beneficiary Patients, Observing The Technical, Quantitative Specifications And Other Conditions Contained In This Terms Of Reference And In The Preliminary Technical Study Id 39444098.. Abiraterone Acetate, Adalimumabe, Apalutamide, Baricitinib, Belimumabe, Belimumabe, Belimumabe, Cladribine, Eculizumabe, Enzalutamide, Fingolimod Chlordrato, Fulvestrant, Infliximabe, Leflunomide, Letrozol, Leuprorelina Acetate, Methotrexate, Mycophenolate, Mycophenolate, Natalizumab, Ocrelizumab, Pirfenidone, Sirolimo, Sirolimo, Tacrolimus, Tamoxifen Citrate, Tofacitinib, Upadacitinib, Ustequinumab, Vedolizuma
Key Value
Tender Value
Ref. Document
Tender Documents
Global Tender Document
506278e2-7df2-4fb5-b758-b4b2fbe19ef5.html
Attachments
Additional Details Available on Click
- Tendering Authority
- Publication Document (Tender Document / Tender Notice)
Disclaimer
We take all possible care for accurate & authentic tender information. However, users are requested to refer to the original Tender Notice / Tender Document published by the Tender Issuing Agency before taking any decision regarding this tender.